Medication leaflets

Active substance

Results for the substance follitropin alfa lutropin alfa

4 results

About this active substance

Follitropin alfa and lutropin alfa are two recombinant hormones used together in fertility treatments to stimulate the ovaries in women with ovarian insufficiency or poor response to stimulation. Follitropin alfa stimulates follicle development, while lutropin alfa (luteinizing hormone) supports oocyte maturation and ovulation.

They are administered by subcutaneous injection, following a personalized protocol set by the fertility specialist. The dose and duration of treatment are adjusted based on individual response and ultrasound and hormonal monitoring. Strict adherence to medical instructions is essential for therapy success.

Side effects may include injection site reactions, bloating, headaches, abdominal discomfort, or, more rarely, ovarian hyperstimulation syndrome. Allergic reactions or mood changes may also occur and should be reported to the doctor.

The combination of follitropin alfa and lutropin alfa provides an effective solution for women with complex fertility issues, but the treatment requires close medical supervision to prevent complications and ensure the best outcomes.